Open AccessIncidence of multidrug-resistant organisms causing ventilator-associated pneumonia in a tertiary care hospital: A nine months' prospective study
Author(s) -
Arindam Dey,
Indira Bairy
Publication year - 2007
Publication title -
annals of thoracic medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.639
H-Index - 33
eISSN - 1817-1737
pISSN - 1998-3557
DOI - 10.4103/1817-1737.32230
Subject(s) - medicine , ventilator associated pneumonia , incidence (geometry) , multiple drug resistance , tertiary care , pneumonia , emergency medicine , prospective cohort study , intensive care medicine , hospital acquired pneumonia , pediatrics , drug resistance , microbiology and biotechnology , physics , optics , biology
Ventilator-associated pneumonia (VAP) is an important intensive care unit (ICU) infection in mechanically ventilated patients. VAP occurs approximately in 9-27% of all intubated patients. Due to the increasing incidence of multidrug-resistant organisms in ICUs, early and correct diagnosis of VAP is an urgent challenge for an optimal antibiotic treatment.